Learn More
Pre-existing anti-RhD-alloantibodies in allogeneic bone marrow donors are relatively seldom observed and may lead to hemolytic post transplant complications in RhDmismatched recipients. We describe(More)
BACKGROUND Autologous peripheral blood stem cell transplantation (PBSCT) is commonly used in the treatment of lymphoma patients. G-CSF is widely used to boost white blood cell recovery. However,(More)
Although allogeneic bone marrow transplantation (BMT) has the potential to cure patients with paroxysmal nocturnal hemoglobinuria (PNH), experience with transplantation from matched unrelated donor(More)
  • 1